Amniotic Membrane Market Poised for Steady Growth, Reaching $1.7 Billion by 2030

PORTLAND, OR, UNITED STATES, June 25, 2025 /EINPresswire.com/ -- The global amniotic membrane market is experiencing a consistent upward trend, driven by advancements in regenerative medicine, growing awareness about wound care, and increasing ophthalmic procedures. Valued at $1,102.45 million in 2020, the market is projected to reach $1,728.05 million by 2030, growing at a CAGR of 4.6% from 2021 to 2030.

What Is Amniotic Membrane?
Amniotic membrane (AM), or amnion, is a biological tissue from the innermost layer of the placenta. It has anti-inflammatory, anti-scarring, and regenerative properties, making it valuable in ophthalmology, wound care, and surgical applications.

Get a Sample Copy of this Report: https://www.alliedmarketresearch.com/request-sample/4559

Key Drivers of Market Growth
✅ Technological advancements in cryopreservation and lyophilization techniques

✅ Increased adoption in eye surgeries and wound care due to faster recovery times

✅ Rising geriatric population and prevalence of chronic wounds

✅ Growing awareness about biological grafts and their benefits

✅ Government initiatives to strengthen healthcare infrastructure in emerging nations

COVID-19 Impact: Temporary Slowdown, Long-Term Growth
While the COVID-19 pandemic disrupted elective procedures and wound care services, resulting in short-term setbacks, the demand for AM-based products is expected to bounce back strongly due to resumed surgeries and increased focus on tissue regeneration.

Market Segmentation Overview
🔬 By Product
Cryopreserved Amniotic Membrane

Dominated the market in 2020

Retains biological activity, widely used in visual and reconstructive surgeries

Lyophilized Amniotic Membrane

Expected to grow at the fastest rate

Easier storage, long shelf life, and fewer adverse reactions

🩺 By Application
Surgical Wounds (Leading Segment)

Benefits include scar reduction and accelerated healing

Ophthalmology

Widely used in ocular surface reconstruction

Others

Includes burns, chronic ulcers, and gynecological uses

🏥 By End User
Hospitals

Leading segment due to high patient footfall and surgical volumes

Ambulatory Surgical Centers & Specialized Clinics

Gaining traction with focus on outpatient procedures

🌍 By Region
North America

Largest market with strong research infrastructure

Expected to maintain dominance with 8.0% CAGR

Asia-Pacific

Fast-growing market due to aging population and expanding healthcare access

Europe & LAMEA

Steady growth expected, driven by increasing transplant procedures and innovation adoption

Competitive Landscape
Key players are focusing on product innovation, partnerships, and geographic expansion to strengthen their position. Leading companies include:

Allosure, Inc.

Amnio Technology, LLC

Applied Biologics LLC

Integra Lifesciences Holdings Corp.

MiMedx Group, Inc.

Skye Biologics Inc.

TissueTech, Inc.

Future Outlook
The amniotic membrane market holds significant potential, particularly in developing regions. Innovations in bioengineering, increased clinical trials, and a shift towards biological solutions in wound care and eye treatments will likely shape the market landscape in the years ahead.

Summary Bullet Points
📈 Market to grow from $1.1B in 2020 to $1.7B by 2030

👁️ Dominated by applications in surgical wounds and ophthalmology

❄️ Cryopreserved AM leads in usage; Lyophilized AM growing rapidly

🌐 North America leads, Asia-Pacific shows fastest potential

🏥 Hospitals remain the largest end users

🔬 Innovation and awareness are key growth levers

Enquire Before Buying: https://www.alliedmarketresearch.com/purchase-enquiry/4559

David Correa
Allied Market Research
+ 1800-792-5285
email us here
Visit us on social media:
LinkedIn
Facebook
YouTube
X